Why the study?
Does slow-release verapamil compared to nitrendipine reduce office and 24-hour ambulatory blood pressure in patients with mild-to-moderate hypertension?
Does slow-release verapamil compared to nitrendipine reduce office and 24-hour ambulatory blood pressure in patients with mild-to-moderate hypertension?
Both slow-release verapamil and nitrendipine are similarly effective in reducing office and daytime ambulatory blood pressure in mild-to-moderate hypertension without altering heart rate.
Answers are grounded in this paper and cite their sources.
Verapamil SR matches nitrendipine for office and ambulatory BP reduction; confirms equivalence as options in mild-to-moderate hypertension.
The aim of the present study was to compare the effects of slow-release verapamil (V), 240 mg and nitrendipine (N), 20 mg, administered once daily, on office (OBP) and 24-h ambulatory blood pressure (ABP) in patients with mild-to-moderate hypertension. Twenty patients were entered into this open, randomized, two-group (V, N) parallel study. The study groups had similar age and sex distribution. The OBP (V, 155/103 +/- 19/8 mm Hg; N, 141/98 +/- 13/4 mm Hg), heart rate (HR) (V, 74 +/- 7 beats/min; N, 77 +/- 10 beats/min), daytime systolic ABP (V, 149 +/- 14 mm Hg; N, 147 +/- 13 mm Hg), and nighttime ABP of the two groups were not statistically different after a 2-week washout period. The daytime diastolic ABP (V, 99 +/- 6 mm Hg; N, 93 +/- 6 mm Hg) was slightly lower (p less than 0.05) in group N. Both the OBP (V, 136/90 +/- 19/9 mm Hg; N, 135/85 +/- 10/4 mm Hg) and daytime ABP (V, 132/85 +/- 14/4 mm Hg; N, 136/87 +/- 13/8 mm Hg) dropped in the two groups after 8 weeks of treatment. Nonparametric analysis did not show statistical differences between the groups in OBP and ABP percentage drop. There was no significant change in nighttime ABP, HR (V, 73 +/- 10 beats/min; N, 74 +/- 12 beats/min), ECG, and laboratory exams. We conclude that both verapamil SR and nitrendipine are effective in reducing blood pressure in hypertensive patients without altering the HR.
No takes yet. Share an insight, caveat, or question.
Pannarale et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: